ECL ECOLAB INC.
Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics · NYSE · SEC CIK 31462 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY9.3%
TTM net income YoY4.9%
TTM EPS YoY5.6%
Revenue 3-yr CAGR4.9%
Net income 3-yr CAGR19.1%
Margins
Gross margin43.9%
Operating margin16.7%
Net margin12.0%
FCF margin10.3%
EBITDA margin20.9%
Returns
ROE20.7%
ROA7.6%
ROIC (approx.)12.1%
Asset turnover0.63x
Leverage & solvency
Liabilities / assets66.4%
Debt / equity1.27x
Current ratio1.11x
Interest coverage7.42x
Cash quality & payout
Operating cash flow / net income1.45x
Accruals ratio-3.4%
Payout ratio39.3%
Capex / revenue7.1%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $16.08B | $15.74B | $15.32B | $14.19B | $12.73B |
| Cost of revenue | $8.93B | $8.90B | $9.15B | $8.83B | $7.62B |
| Gross profit | $7.15B | $6.84B | $6.17B | $5.36B | $5.12B |
| R&D expense | $202.00M | $207.00M | $192.00M | $190.00M | $186.00M |
| SG&A expense | $4.26B | $4.23B | $4.06B | $3.65B | $3.42B |
| Operating income | $2.74B | $2.80B | $1.99B | $1.56B | $1.60B |
| Interest expense | $306.20M | $340.30M | $348.90M | $252.10M | $230.60M |
| Pretax income | $2.55B | $2.57B | $1.76B | $1.34B | $1.41B |
| Income tax | $454.60M | $439.30M | $362.50M | $234.50M | $270.20M |
| Net income | $2.08B | $2.11B | $1.37B | $1.09B | $1.13B |
| EBITDA | $3.41B | $3.44B | $2.61B | $2.18B | $2.20B |
| EPS (basic) | 7.33 | 7.43 | 4.82 | 3.83 | 3.95 |
| EPS (diluted) | 7.28 | 7.37 | 4.79 | 3.81 | 3.91 |
| Dividends declared per share | 2.68 | 2.36 | 2.16 | 2.06 | 1.95 |
| Weighted avg. shares (diluted) | 285.20M | 286.60M | 286.50M | 286.60M | 289.10M |
| Balance sheet | |||||
| Cash & equivalents | $646.20M | $1.26B | $919.50M | $598.60M | $359.90M |
| Receivables | $3.25B | $2.87B | $2.83B | $2.70B | $2.48B |
| Inventory | $1.49B | $1.46B | $1.50B | $1.79B | $1.49B |
| Current assets | $5.96B | $6.03B | $5.64B | $5.49B | $4.69B |
| PP&E, net | $4.28B | $3.75B | $3.47B | $3.29B | $3.29B |
| Goodwill | $9.23B | $7.91B | $8.15B | $8.01B | $8.06B |
| Intangibles | $3.69B | $3.31B | $3.49B | $3.68B | $4.22B |
| Total assets | $24.70B | $22.39B | $21.85B | $21.46B | $21.21B |
| Current liabilities | $5.53B | $4.79B | $4.35B | $4.21B | $3.55B |
| Short-term debt | $870.40M | $615.70M | $630.40M | $505.10M | $411.00M |
| Long-term debt | $7.37B | $6.95B | $7.55B | $8.08B | $8.35B |
| Total debt | $8.24B | $7.56B | $8.18B | $8.58B | $8.76B |
| Total liabilities | $14.89B | $13.60B | $13.77B | $14.21B | $13.95B |
| Shareholders' equity | $9.77B | $8.76B | $8.04B | $7.24B | $7.22B |
| Net debt | $7.59B | $6.31B | $7.26B | $7.98B | $8.40B |
| Shares outstanding | 282.00M | 283.40M | 285.40M | 284.50M | 286.90M |
| Cash flow statement | |||||
| Operating cash flow | $2.95B | $2.81B | $2.41B | $1.79B | $2.06B |
| Capital expenditure | $1.05B | $994.50M | $774.80M | $712.80M | $643.00M |
| Free cash flow | $1.90B | $1.82B | $1.64B | $1.08B | $1.42B |
| Investing cash flow | -$2.71B | -$433.80M | -$990.50M | -$716.80M | -$4.58B |
| Financing cash flow | -$853.30M | -$2.02B | -$1.05B | -$837.30M | $1.60B |
| Depreciation & amortization | $672.60M | $634.90M | $616.70M | $618.50M | $604.40M |
| Stock-based compensation | $136.60M | $134.80M | $95.10M | $87.80M | $89.50M |
| Dividends paid | $753.60M | $664.30M | $617.30M | $602.80M | $566.40M |
| Share buybacks | $783.80M | $986.50M | $13.70M | $518.20M | $106.60M |
Free plan shows the latest 5 periods; Pro shows all 19 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.